Offer - Urjas Oil for just ₹ 1 X
Turbovas F is a prescription drug, available for use as Tablet. The alternative uses of Turbovas F have also been explained below.
The optimal dosage of Turbovas F is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Turbovas F are Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Turbovas F as well, which are listed below. Usually, these side effects of Turbovas F go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Turbovas F has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Turbovas F has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Turbovas F related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Turbovas F since this can cause severe adverse effects.
Additionally, Turbovas F may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Turbovas F is not safe while driving, and is is not addictive in nature.
Turbovas F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Turbovas F safe for pregnant women?
Turbovas F can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Turbovas F right away. Take your doctor's advice before taking it again.
Is the use of Turbovas F safe during breastfeeding?
Turbovas F may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Turbovas F, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Turbovas F.
What is the effect of Turbovas F on the Kidneys?
Turbovas F has very mild side effects on the kidneys.
What is the effect of Turbovas F on the Liver?
Turbovas F may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Turbovas F on the Heart?
Turbovas F can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Turbovas F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Turbovas F unless your doctor advises you to do so -
Is this Turbovas F habit forming or addictive?
Turbovas F is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Turbovas F. So it is best to avoid driving.
Is it safe?
Yes, but take Turbovas F only as per medical advice.
Is it able to treat mental disorders?
Turbovas F is unable to treat or cure mental disorders.
Interaction between Food and Turbovas F
Information is not available on the interaction of any foods with Turbovas F, due to a lack of research on this.
Interaction between Alcohol and Turbovas F
No research has been done on this till date. Therefore, it is not known what the effect of taking Turbovas F with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650